Domov › Steatotična bolezen jeter › Florida › Miami

Klinične študije za Steatotična bolezen jeter v Miami, FL

16 študij za Steatotična bolezen jeter išče udeležence na lokacijah v Miami in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Vključevanje udeležencevFaza 3

89bio Clinical Study Site, Miami
89bio Clinical Study Site, Miami
89bio Clinical Study Site, Miami

Starost 18–75 · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT06419374

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Vključevanje udeležencevFaza 3

89bio Clinical Study Site, Miami

Starost 18–80 · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT06318169

A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

Vključevanje udeležencevFaza 3

GSK Investigational Site, Miami
GSK Investigational Site, Miami

Starost 18–75 · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07704892

A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

Vključevanje udeležencevFaza 3

GSK Investigational Site, Miami
GSK Investigational Site, Miami

Starost 18–75 · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07701993

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

Vključevanje udeležencevFaza 2

Evolution Clinical Trials, Miami

Starost 18–75 · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT07527910

Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

Vključevanje udeležencevFaza 2

University of Miami Health System, Miami

Starost 18–75 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT05832229

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

Vključevanje udeležencevFaza 2

Genoma Research Group, Inc., Miami
Med Research of Florida, LLC, Miami

Starost 18–75 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT05519475

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Vključevanje udeležencevFaza 3

Evolution Clinical Trials, Miami

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Vključevanje udeležencevFaza 3

Akero Clinical Study Site, Miami
Akero Clinical Study Site, Miami

Starost 18–80 · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT06528314

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

Vključevanje udeležencevFaza 3

GSK Investigational Site, Miami
GSK Investigational Site, Miami
GSK Investigational Site, Miami
in še 3

Starost 18–75 · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT07221188

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

Vključevanje udeležencevFaza 2

Evolution Clinical Trials, Miami

Starost 18–75 · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07288138

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

Vključevanje udeležencevFaza 2

GSK Investigational Site, Miami

Starost 18–70 · Vsi spoli · Posodobljeno 3. avg. 2026 · NCT06613698

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

Vključevanje udeležencevFaza 3

GSK Investigational Site, Miami
GSK Investigational Site, Miami
GSK Investigational Site, Miami
in še 4

Starost 18–75 · Vsi spoli · Posodobljeno 27. jul. 2026 · NCT07221227

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

Vključevanje udeležencevFaza 2

GSK Investigational Site, Miami

Starost 18–75 · Vsi spoli · Posodobljeno 8. jul. 2026 · NCT06920043

A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Vključevanje udeležencevFaza 1/2Vabljeni zdravi prostovoljci

Genoma Research Group, Inc, Miami
Med Research of Florida, LLC, Miami

Starost 18–75 · Vsi spoli · Posodobljeno 16. apr. 2026 · NCT05648214

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

Vključevanje udeležencevOpazovalna študija

Clinical Pharmacology of Miami, Miami

Starost 18–75 · Vsi spoli · Posodobljeno 14. avg. 2025 · NCT07122700

Študije za Steatotična bolezen jeter v drugih mestih

Druge študije v Miami

Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.